Oprelvekin
Overview
Categories
- 8 Antineoplastics, immunomodulators and drugs used in palliative care
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Oprelvekin's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 25 mcg/Kg | 25 (25) | As recommended. | SC | with severe renal impairment. Dosing should be initiated six to 24 hours after the completion of chemotherapy |
| 50 mcg/Kg | 50 (50) | As recommended. | SC | without severe renal impairment. Dosing should be initiated six to 24 hours after the completion of chemotherapy |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Oprelvekin is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Oprelvekin is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Oprelvekin
Back to top
Previous Drug Generic - Next Drug Generic